Publicacións nas que colabora con Esperanza Pato Cour (19)

2022

  1. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

2021

  1. Inflammatory Relapses after Immunosuppressive Drug Discontinuation in Uveitis Patients: A Survival Analysis

    Ocular Immunology and Inflammation, Vol. 29, Núm. 2, pp. 376-387

2020

  1. Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis

    JCR: Journal of Clinical Rheumatology

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

  2. Visual acuity loss and development of ocular complications in white dot syndromes: a longitudinal analysis of 3 centers

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, Núm. 11, pp. 2505-2516

2018

  1. Disease Remission in Children and Adolescents with Intermediate Uveitis: A Survival Analysis

    Ophthalmologica, Vol. 239, Núm. 2-3, pp. 151-158

  2. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

  3. Vision-related Quality of Life in Patients with Non-infectious Uveitis: A Cross-sectional Study

    Ocular Immunology and Inflammation, Vol. 26, Núm. 5, pp. 717-725

2017

  1. Development of an activity disease score in patients with uveitis (UVEDAI)

    Rheumatology International, Vol. 37, Núm. 4, pp. 647-656

  2. Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review

    Ocular Immunology and Inflammation, Vol. 25, Núm. 5, pp. 604-609

2016

  1. Immunosuppressive Drug Discontinuation in Noninfectious Uveitis From Real-Life Clinical Practice: A Survival Analysis

    American Journal of Ophthalmology, Vol. 169, pp. 1-8

  2. Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: A survival analysis

    British Journal of Ophthalmology, Vol. 100, Núm. 12, pp. 1651-1655

2015

  1. Study of association of CTLA4 gene variants to non-anterior uveitis

    Tissue Antigens, Vol. 86, Núm. 5, pp. 373-376

2013

  1. No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis

    PLoS ONE, Vol. 8, Núm. 11

  2. Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. Long-term use of antimalarial drugs in rheumatic diseases

    Clinical and Experimental Rheumatology, Vol. 30, Núm. 3, pp. 380-387

2009

  1. Treatment of refractory posterior uveitis with infliximab: A 7-year follow-up study

    Scandinavian Journal of Rheumatology, Vol. 38, Núm. 1, pp. 58-62

2008

  1. Enfermedades articulares y uveítis

    Anales del sistema sanitario de Navarra, Vol. 31, Núm. 3, pp. 83-95

  2. Ocular inflammatory signs observed in a cohort of Spanish patients with Behçet disease and ocular inflammation

    European Journal of Ophthalmology, Vol. 18, Núm. 4, pp. 563-566